Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability

OBJECTIVE: Demonstrate rapid initiation of co-formulated treatment during acute HIV infection (AHI) is feasible and efficacious. DESIGN: Prospective, single-arm open label study of once daily emtricitabine/tenofovir/efavirenz initiated during AHI. METHODS: We provide final data through week 96-week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: GAY, Cynthia L., WILLIS, Sarah J., COPE, Anna B., KURUC, JoAnn D., MCGEE, Kara S., SEBASTIAN, Joe, CROOKS, Amanda M., MCKELLAR, Mehri S., MARGOLIS, David M., FISCUS, Susan A., HICKS, Charles B., FERRARI, Guido, ERON, Joseph J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101138/
https://ncbi.nlm.nih.gov/pubmed/27662549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados